logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/07/2025
GlaxoSmithKline has stated that it has submitted an application to the US FDA to expand the use of its respiratory syncytial virus (RSV) vaccine Arexvy to adults aged 18 to 49 years old at higher risk of contracting the disease.
Latest
2 m ago
Meinian Health: It is expected that the net profit will be a loss of 192 million to 236 million yuan in the first half of 2025.
2 m ago
Green City Water: Net profit is expected to decrease by 54.29% to 69.04% year-on-year in the first half of the year.
2 m ago
Market news: Renowned journalist Guerman stated that Apple is considering acquiring the French artificial intelligence startup Mistral AI.
2 m ago
Jiangsu Inovance Technology Co., Ltd. (603680.SH) issued a forecast indicating that the net profit attributable to shareholders for the first half of the year is expected to be between 330 million yuan and 380 million yuan, a year-on-year increase of 123.85% to 157.77%.
3 m ago
Yonex badminton has increased prices to a maximum of 75 yuan.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.